Canaccord Genuity Boosts Cree (CREE) PT to $37

Go back to Canaccord Genuity Boosts Cree (CREE) PT to $37

Piper Jaffray Assumes Cree (CREE) at Overweight

January 23, 2013 7:56 AM EST

Piper Jaffray assumes coverage on Cree (NASDAQ: CREE) with a Overweight. PT $43.00.

For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.

Shares of Cree closed at $33.47 yesterday, with a 52 week range of $22.25-$35.09.... More

Needham & Company Lifts PT on Cree (CREE) on 'Strong' Q2

January 23, 2013 7:43 AM EST

Needham & Company raised its price target on Buy-rated Cree (NASDAQ: CREE) from $36 to $42 post Q2.

The firm comments, "CREE reported a strong F2Q13 (Dec) and provided guidance above the Streets estimates. The top-line growth and continued margin expansion in both the LED... More

Cree, Inc. (CREE) Tops Q2 EPS by 2c; Guides Q3 EPS, Revs Above

January 22, 2013 4:01 PM EST

Cree, Inc. (NASDAQ: CREE) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $346.3 million versus the consensus estimate of $331.2 million.

Cree, Inc. sees Q3 2013 EPS of $0.30-0.35, versus the consensus of $0.28. Cree, Inc. sees Q3 2013... More